Aldevron, L.L.C.

ALDEVRON

Contract manufacturing in the field of biologics for research, clinical, and diagnostic applications including ready-to-use AAV helper, cytokine, and reporter plasmids;In the statement, line 1, ALDEVRON should be deleted, and ALDEVRON, L.L.C. should be inserted.;

ALDEVRON

Biological preparations for use in the treatment of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases; diagnostic preparations for medical and veterinary purposes; diagnostic reagents for medical and veterinary purposes; nucleic acid sequences for medical and veterinary purposes; enzymes for medical and veterinary purposes; protein arrays for medical and veterinary diagnosis purposes; antibodies, namely, monoclonal and polyclonal antibodies for the diagnosis, treatment, and prevention of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases;Biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for in vitro, in vivo and ex vivo scientific and research use; diagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use; nucleic acids for scientific and research use; proteins in raw material form for scientific and medical research; enzymes for scientific and research use; biochemicals, namely, monoclonal and polyclonal antibodies for in vitro, in vivo, and ex vivo scientific and research use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro, in vivo, and ex vivo diagnostic use; biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for use in biotechnological product development;

ALDEVRON

Manufacturing services for others in the field of biologics for research, clinical and diagnostic applications; technical consultancy services, namely, providing technical advice and information to others related to the manufacture of biologics for research, clinical and diagnostic applications;The mark consists of the word aldevron in lower case type with a design consisting of multiple triangles, which form a partial image of a multi-point-star, appearing to the left of the word and above the letter a thereof.;Biological preparations for use in the treatment of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases; diagnostic preparations for medical and veterinary purposes; diagnostic reagents for medical and veterinary purposes; nucleic acid sequences for medical and veterinary purposes; enzymes for medical and veterinary purposes; protein arrays for medical and veterinary diagnosis purposes; antibodies, namely, monoclonal and polyclonal antibodies for the diagnosis, treatment, and prevention of cancer, immune response disorders, genetic conditions, infectious diseases, and vascular diseases;Color is not claimed as a feature of the mark.;Biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for in vitro, in vivo and ex vivo scientific and research use; diagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use; nucleic acids for scientific and research use; proteins in raw material form for scientific and medical research; enzymes for scientific and research use; biochemicals, namely, monoclonal and polyclonal antibodies for in vitro, in vivo, and ex vivo scientific and research use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro, in vivo, and ex vivo diagnostic use; biochemicals, namely, ribonucleic acids, deoxyribonucleic acids, peptides, proteins, and antibodies for use in biotechnological product development;

GMP-SOURCE

Manufacturing services for others in the field of biologics for research, clinical and diagnostic applications; manufacturing services for others, namely, custom production of nucleic acids, peptides and proteins under clinical phase-appropriate quality systems; manufacturing services for others, namely, custom production of nucleic acids, peptides and proteins for use in biotechnological product development; technical consultancy services, namely, providing technical advice and information to others related to the manufacture of biologics for initiating clinical studies;

NEOGMP

Manufacturing services for others in the field of biologics for research, clinical, and diagnostic applications; technical consultancy services, namely, providing technical advice and information to others related to the manufacture of biologics for research, clinical, and diagnostic applications;Scientific and technological research and development services in the field of nucleic acid, protein, and enzyme activity; scientific and technological research and development services in the field of biologics; design and development of nucleic acids, proteins, and enzymes for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics;

SPYFI

nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels derived from biotechnological processes for use in scientific and research purposes; nucleases and nuclease panels for use in genetic research, genome editing, and genetic editing; nucleases;

THE BASIS FOR BREAKTHROUGHS

Manufacturing services for others in the field of biologics for research, clinical and diagnostic applications; technical consultancy services, namely, providing technical advice and information to others related to the manufacture of biologics for research, clinical and diagnostic applications;